There are a number of antitumor antibodies
developed that can target specific growth factor receptors on the cancer cell.
a Garden Grove, California-based corporation, has entered into an agreement with Dalat Nuclear Research Institute to co-develop a number of cancer drugs, utilizing combinations of antitumor antibodies and antitumor radioactive compounds.
has been engaged in developing antitumor antibodies, so this is a natural fit to co-develop these novel drugs.
The result of this work suggests that antitumor antibodies
in the blood may provide a fruitful source of sensitive biomarkers for cancer detection.
Other companies are also working on antitumor antibodies
or on smaller molecules that will block the IGF-1 receptor.
The vaccine's ability to produce active antitumor antibodies
is also being tested.
In cancer, immune therapy may involve stimulating thepatient's own response, or substituting for that response with outside factors like antitumor antibodies